MiMedx Group, Inc. Cash and Restricted Cash
MiMedx Group, Inc. (MDXG) had Cash and Restricted Cash of $135.84 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-29
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $135.84M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $159.77M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $166.12M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $142.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $135.84M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $159.77M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $166.12M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $142.08M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $118.87M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $106.43M 10-Q · filed 2026-04-29 |
| 2024-12-31 | $104.42M 10-Q · filed 2026-07-29 |
| 2024-09-30 | $88.80M 10-Q · filed 2025-10-29 |
| 2024-06-30 | $69.04M 10-Q · filed 2025-07-30 |
| 2024-03-31 | $48.49M 10-Q · filed 2025-04-30 |
| 2023-12-31 | $82.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | $81.16M 10-Q · filed 2024-10-30 |
| 2023-06-30 | $68.65M 10-Q · filed 2024-07-31 |
| 2023-03-31 | $61.22M 10-Q · filed 2024-04-30 |
| 2022-12-31 | $65.95M 10-K · filed 2026-02-25 |
| 2022-09-30 | $73.22M 10-Q · filed 2023-10-30 |
| 2022-06-30 | $72.50M 10-Q · filed 2023-08-01 |
| 2022-03-31 | $75.68M 10-Q · filed 2023-05-02 |
| 2021-12-31 | $87.08M 10-K · filed 2025-02-26 |
| 2021-09-30 | $90.61M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $85.01M 10-Q · filed 2022-08-02 |
| 2021-03-31 | $84.75M 10-Q · filed 2022-05-03 |
| 2020-12-31 | $95.81M 10-K · filed 2024-02-28 |
| 2020-09-30 | $109.59M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $48.19M 10-Q · filed 2021-08-03 |
| 2020-03-31 | $53.52M 10-Q · filed 2021-04-28 |
| 2019-12-31 | $69.07M 10-K · filed 2023-02-28 |
| 2019-09-30 | $94.12M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $96.93M 10-Q · filed 2020-08-04 |
| 2019-03-31 | $28.38M 10-Q · filed 2020-07-06 |
| 2018-12-31 | $45.12M 10-K · filed 2022-02-28 |
| 2018-09-30 | $45.05M 10-Q · filed 2020-07-06 |
| 2018-06-30 | $44.34M 10-Q · filed 2020-07-06 |
| 2018-03-31 | $26.45M 10-Q · filed 2020-07-06 |
| 2017-12-31 | $27.48M 10-K · filed 2021-03-08 |
| 2016-12-31 | $30.32M 10-K · filed 2020-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |